Enhanced Understanding of Procalcitonin Utilization as an Infection Biomarker in Non-Hodgkin's Lymphoma

Key Points

• The aim is to assess the effectiveness of procalcitonin as an infection biomarker in patients with non-Hodgkin's lymphoma.
• Examined serum procalcitonin levels in non-Hodgkin's lymphoma patients
• Considered tumor stage and evolution in relation to procalcitonin levels
• Recommended hospitalization to establish baseline serum procalcitonin levels
• Elevated serum procalcitonin levels are found in non-Hodgkin's lymphoma patients
• A solitary procalcitonin test proves limited for infection detection
• Establishing a baseline level through hospitalization is beneficial for diagnostics

Abstract